CompaniesInvestorsPeople
Home
Loading

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

Get in Touch

  • Contact

  • Request a Demo

  • Request Data Updates

  • Add a Company

Research

  • Companies

  • Investors

  • People

aVenture

  • Download App

  • Pricing

Download the aVenture Research beta for iOS and iPadOSDownload aVenture Research on the Mac App Store

Resources

  • Documentation

  • Use Cases

  • CLI

  • MCP

  • Feature Requests

  • Sitemap

Member

Backed by

Ask AI about aVenture

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy · Terms of Service

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading
Loading
Home
News
Bluu Seafood reels in $17.5M to bring cultivated fish products to market

From TechCrunch

By Paul Sawers

June 28, 2023

Bluu Seafood reels in $17.5M to bring cultivated fish products to market

Bluu Seafood reels in $17.5M to bring cultivated fish products to market

Bluu Seafood, a German company creating cultivated (i.e. “lab-grown”) fish products, today announced it has raised €16 million ($17.5 million) in a Series A round of funding.

Founded out of Berlin in 2020 originally as Bluu Biosciences, Bluu Seafood starts with a “one-time” fish biopsy — which, it says, doesn’t require killing any fish — and then uses stem-cell technology to grow entire cell lines (i.e. fish species) inside a lab.

The company unveiled its first products last August, including a line of fish sticks (or “fish fingers”) and fish balls. These are made from cultivated fish cells that are enriched with plant proteins, a process it says helps make their mouth-feel and cooking process more realistic.

bowl of lab-grown seafood

Bluu Seafood’s cultivated fish balls Image Credits: Bluu Seafood

Production problems

Bluu Seafood is one of numerous biotech startups that are setting out to address the world’s seafood production problems, which includes overfishing, contamination, and cruelty. But the movement is not limited to marine animals, with countless companies raising bucketloads of VC cash to reproduce everything from bacon to burgers and chicke and beyond.

Bluu Seafood, for its part, had raised €7.1 million in funding so far, and with another €16 million in the bank it’s now gearing up to attain regulatory approval in various markets, including Singapore which is currently the only market in the world where cultured meat (chicken) is available to buy. However, the Food and Drug Association (FDA) also started rubberstamping such edibles as being safe for human consumption, and just this week it approved two companies to begin selling their lab-grown chicken products — so we can expect some commercial activity in the U.S. in the very near future.

First up, Bluu Seafood is aiming to enter Singapore, where it says it expects to receive approval some time in 2024, while it says it has also kickstarted the approval process with the FDA, and will then set about targeting the European market.

Bluu Seafood’s Series A round was led by Sonae-subsidiary Sparkfood and LBBW VC, with participation from Delivery Hero, SeaX Ventures, Manta Ray Ventures, Norrsken VC,  Hamburgische Investitions- und Förderbank and Dr. Oetker.

Bluu Seafood reels in $17.5M to bring cultivated fish products to market by Paul Sawers originally published on TechCrunch

Most Recent

NextDC's stock fell as much as 44% to A$5.15 after the Australian data center company cut its earnings forecast by over a third; shares were above A$16 in June

NextDC plunge adds to sector woes as Nvidia holds talks over injecting capital into Firmus after failed IPO

Oct 20, 2026

Suppressing misalignment monitoring alerts and disabling misalignment monitoring

Research on aligning AI with human values and intent, and reports documenting model failures.

Oct 20, 2026

Fidelity launches global innovators equity fund in Hong Kong and Singapore

The new Luxembourg-domiciled SICAV fund will invest in companies positioned to drive or benefit from structural change and long-term trends.

Oct 20, 2026

Australian data center operator NextDC's shares plunge 40% after it slashes earnings forecast

The company cited power supply delays at its Melbourne facility amid local community and stakeholder opposition for lowering earnings forecast.

Oct 20, 2026

Similar Posts

Alternative seafood startup Aqua Cultured Foods reels in $5.5M

Aqua Cultured Foods is using proprietary mycoprotein (fungi) fermentation processes to create whole cuts of calamari, shrimp, scallops and filets of tuna and whitefish.

Apr 6, 2023

Indonesian aquaculture startup eFishery nets $200M at unicorn valuation

After reports that it is raising new funding, Indonesian aquaculture startup eFishery announced today that it has netted $200 million in a Series D. The company, which makes a smart feeding system for fisheries, says this makes it the first startup in the global aquaculture industry to pass a $1 billion valuation. It’s goal is […]

Jul 7, 2023

Cultured meat startup Higher Steaks nabs $30M and rebrands as Uncommon

U.K.-based cultivated meat startup Higher Steaks has raised $30 million in a Series A round of funding and revealed that it’s changing its name to Uncommon. Founded out of Cambridge in 2017, Uncommon is one of countless companies pushing to make cultured “lab-grown” meat a reality in kitchens and restaurants around the globe, covering everything […]

Jun 8, 2023

Wanda Fish navigates VC waters to catch $7M for production of cultivated bluefin tuna

The company aims to create whole-cut cultivated fish filets, starting with bluefin tuna, using muscle and fat cells.

Oct 9, 2023